AI Article Synopsis
- The study synthesized NH-bridged tetradentate ligands to create stable trans Ru(II) bis(polypyridyl) complexes, using both symmetric and asymmetric polypyridyl components.
- The initial complex, trans-[Ru(phen-NH-phen)Cl2], was formed by protonating a symmetric ligand and reacting it with RuCl3, allowing for easy replacement of chloro ligands with stronger ones like CH3CN and DMSO.
- This research led to the first identified trans ruthenium(II) bis(polypyridyl) complex featuring two distinct polypyridyl ligands in the equatorial plane, showcasing innovative coordination chemistry.
Article Abstract
NH-Bridged tetradentate ligands were synthesized to achieve stable trans Ru(II) bis(polypyridyl) complexes. The polypyridyl part of the ligand was either symmetric, as in N,N-bis(1,10-phenanthroline-2-yl)amine (phen-NH-phen), or asymmetric, as in N-(1,10-phenanthroline-2-yl)-N-(6-yl-dipyridyl[2,3-a:2',3'-c]phenazine)amine (dppz-NH-phen). Protonation of phen-NH-phen with trifluoroacetic acid and the subsequent reaction with RuCl3 yield trans-[Ru(phen-NH-phen)Cl2]. The chloro ligands in this compound can easily be replaced by stronger ligands, such as CH3CN and DMSO. In this way, complexes trans-[Ru(phen-NH-phen)(CH3CN)(DMSO)](PF6)2 (1), trans-[Ru(phen-NH-phen)(DMSO)2](PF6)2 (2), and trans-[Ru(phen-NH-phen)(CH3CN)2](PF6)2 (3) were obtained. X-ray structures were determined for 1 and 3. Following a procedure similar to that used with phen-NH-phen, the complex trans-[Ru(dppz-NH-phen)(CH3CN)2](PF6)2 (4) was obtained. To our knowledge, this is the first reported trans ruthenium(II) bis(polypyridyl) complex with two different polypyridyl ligands in the equatorial plane.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/ic025719h | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Terpyridine-based ruthenium complexes containing a 4,5-diazafluoren-9-one ligand with light-driven enhancement of biological activity.
Dalton Trans
December 2024
Group of Bioinorganic, Department of Organic and Inorganic Chemistry, Federal University of Ceara, Fortaleza, Brazil.
There has been growing effort in the scientific community to develop new antibiotics to address the major threat of bacterial resistance. One promising approach is the use of metal complexes that provide broader opportunities. Among these systems, polypyridine-ruthenium(II) complexes have received particular attention as drug candidates.
View Article and Find Full Text PDFNear-infrared phosphorescence in a ruthenium(II) complex equipped with a pyridyl-1,2-azaborine ligand.
Dalton Trans
December 2024
Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR), Via Piero Gobetti 101, 40129 Bologna, Italy.
The 4-methyl-2-(pyridin-2-yl)-2,1-borazaronaphthalene molecule Hazab-py has been successfully used, for the first time, as a ligand in a ruthenium(II) polypyridine complex A (with the formula [Ru(dtbbpy)(azab-py)], where dtbbpy = 4,4'-di--butyl-2,2'-bipyridine). This compound was characterized by NMR spectroscopy and high-resolution mass spectrometry (MS), and its electrochemical and photophysical properties were fully investigated and compared to those of its homoleptic analogue [Ru(dtbbpy)] (B), an archetypical mono-cationic cyclometalated complex C (with the formula [Ru(dtbbpy)(ppy)], where Hppy = 2-phenylpyridine), and the more structurally similar analogue [Ru(dtbbpy)(naft-py)] (D), where the B-N unit of the azaborine ligand is replaced by a standard CC one, resulting in the 2-(naphthalen-2-yl)pyridine ligand (Hnaft-py). The presence of the novel 1,2-azaborine ligand induces a 0.
View Article and Find Full Text PDFDehydrogenative Coupling for Synthesis of Quinazolin-4(3H)-ones via Tandem Reaction using Ruthenium(II)-Phenyl-Azo-Naphthaldoxime: An Experimental and Theoretical Investigation.
Chem Asian J
November 2024
Department of Chemistry, St. Xavier's College (Autonomous), Kolkata, 700016, India.
The bidentate N, N, donor phenyl-azo-naphthaldoxime NpLH, 1 was used to synthesize the ruthenium(II) complex trans-[Ru(NpL)(CO)Cl(PPh)], 2. It has been characterized by SCXRD, electrochemical and spectral studies. Computational analysis indicates that the low-lying π*-LUMO of the complex has substantial azo-character of coordinated ligand.
View Article and Find Full Text PDFThe bonding situations in ruthenium chalcogenonitrosyl compounds: a physical reasoning.
Dalton Trans
December 2024
Department of Chemistry, Federal University of Santa Catarina, Florianópolis, Santa Catarina, Brazil.
This research presents, for the first time, a comprehensive and rigorous investigation of ruthenium(II) chalcogenonitrosyl bonding situations in two sets of coordination compounds: [Ru(NE)Cl(L)] (1a-4a) and [Ru(NE)Cl(L)] (1b-4b), where E = O, S, Se, Te. Prior to and following the one-electron reduction, the Ru-NE bonding situations were subjected to analysis. The calculated geometric parameters indicate that both the Ru-NE and N-E bond lengths are susceptible to variation depending on the nature of the chalcogen employed.
View Article and Find Full Text PDFCyrene™ as a green alternative to ,'-dimethylformamide (DMF) in the synthesis of MLCT-emissive ruthenium(II) polypyridyl complexes for biological applications.
Dalton Trans
November 2024
Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK.
Ruthenium(II) polypyridyl complexes (RPCs) that emit from triplet metal-to-ligand charge transfer (MLCT) states find a wide variety of uses ranging from luminophores to potential anti-cancer or anti-bacterial therapeutics. Herein we describe a greener, microwave-assisted synthetic pathway for the preparation of homoleptic [Ru(N^N)] and bis-heteroleptic [Ru(N^N)(N'^N')] type complexes. This employs the bio-renewable solvent Cyrene™, dihydrolevoglucosenone, as a green alternative to ,'-dimethylformamide (DMF) in the synthesis of Ru(N^N)Cl intermediate complexes, obtaining comparable yields for N^N = 2,2'-bipyridine, 1,10-phenanthroline and methylated derivatives.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!